A Comparative Non Randomized clinical trial on Akkini Chooranam and Narambu Pidikku Ottradam and Varmam Adangal alone in the management of Korai Vatham (Lumbar Spondylosis) for the patients reporting at Government Siddha Medical college and Hospital Palayamkottai

AN OPEN LABELLED DOUBLE ARM NON-RANDOMISED PHASE II CLINICAL TRIAL, TO COMPARE THE EFFECTIVENESS OF VARMA ADANGAL WITH AKKINI CHOORANAM (INTERNAL), NARAMBU PIDIKKU OTTRADAM (EXTERNAL) IN THE MANAGEMENT OF KORAI VATHAM (LUMBAR SPONDYLOSIS) - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/107449

Enrollment

Registered

2026-04-02

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M478- Other spondylosis

Interventions

Intervention1: Varma Adangal: Stimulation of Varma Adangal over the Posterior trunk for 14 days. Control Intervention1: Akkini Chooranam (Internal) and Narambu Pidikku Ottradam (External).: Internal

Eligibility

Inclusion criteria

Inclusion criteria: Patient having the symptoms of pain in the middle and low back region,difficulty in bending, Stiffness around the hip, Patients included using ODI scale, Patients who are willing to give radiological investigation and provide blood for lab investigation, Patients who are willing to participate in this study with the knowledge of potential risks and who are willing to sign the informed consent form.

Exclusion criteria

Exclusion criteria: Age: Below 30 Years and Above 70 Years History of fracture, Ligament injury, History of Ankylosing spondylitis, History of Pott s spine, Pregnancy women and lactating mothers, Benign and malignant Neoplasm, Patient with any other Autoimmune Diseases, Patient who are having the skin disease,

Design outcomes

Primary

Measure	Time frame
Reduction in lower back pain and stiffness as measured by the Oswestry Disability Index (ODI).Timepoint: 1,7,14 and 21 days.	—

Secondary

Measure	Time frame
Evaluation of the safety profile and biochemical effects of Akkini Chooranam.Timepoint: 6 months	—

Countries

India

Contacts

Public ContactDr R KRISHNAMOORTHI

Government Siddha Medical College and Hospital ,Palayamkottai

arksiddh@gmail.com9442545017

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026